Respirable drug for treating chronic rhinitis and allergic rhinitis and preparation method of respirable drug

Abstract

The invention belongs to the field of rhinitis treatment drugs and discloses a respirable drug for treating chronic rhinitis and allergic rhinitis and a preparation method of the respirable drug. Therespirable drug for treating chronic rhinitis and allergic rhinitis is prepared from flos magnoliae and calyx meto. The respirable drug is prepared from two traditional Chinese medicines flos magnoliae and calyx meto in a certain ratio for administration in forms of atomization, inhalation, dripping-in and blowing-in, the administration forms are simple, the drug takes effect quickly, a patient has no pain when taking the drug for a long time, the stuffy nose can be relieved rapidly, and symptoms such as dry and itching eyes, googly eyes all along and dizzy head due to anoxia can be relieved;dry pain or sinusitis caused by excessive relief of the nose is avoided; complications caused by chronic rhinitis and the like can be prevented effectively.

Description

technical field [0001] The invention belongs to the field of drugs for treating rhinitis, in particular to an inhalable drug for treating chronic rhinitis and allergic rhinitis and a preparation method thereof. Background technique [0002] At present, the commonly used prior art in the industry is as follows: chronic allergic rhinitis, also known as allergic rhinitis, is an allergic disease of nasal mucosa and can cause various complications. In recent years, the incidence rate has increased and tended to heat up. Chronic allergic rhinitis describes the formation of the etiology, as well as Chinese and Western treatments and prescriptions. and how to take care of it. Chronic allergic rhinitis, also known as allergic rhinitis, is an allergic disease of the nasal mucosa and can cause various complications. In recent years, the incidence rate has increased and tended to heat up. According to statistics, allergic rhinitis accounts for about 40% of all rhinitis. Clinically,...

AI Technical Summary

Problems solved by technology

2. Inferior turbinate mucosa electrocautery, freezing, laser and other treatments can reduce the sensitivity of nerve endings

[0005] (1) Desensitization therapy Some allergens are difficult to avoid, such as a large amount of pollen floating in the air during the pollen season, dust mites and fungi that exist indoors all year round;

[0006] (2) Local treatment can reduce the sensitivity of nerve endings

[0008] (1) The disease is recurrent and cannot be cured. Long-term medication will make the patient suffer physically and mentally. This is the biggest difficulty

Images